Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cantor Fitzgerald

Lucid Shows Huge Unusual Put Options Activity After Disappointing Results

Lucid Group, the luxury electric vehicle maker, produced poor results. Barchart reports two large unusual tranches of puts traded today, indicating a pessimistic investor outlook for LCID stock.

Barchart

Sarah Ferguson says she was ‘meant to be’ at World Trade Center on 9/11 as she pays tribute to victims

‘I was meant to be there that morning 22 years ago but an interview ran late,’ the duchess recalls

The Independent UK

Markets Today: Stocks Firm on Hopes for Additional Chinese Stimulus

Morning Markets June E-Mini S&P 500 futures (ESM23 ) this morning are up +0.19%, and June Nasdaq 100 E-Mini futures (NQM23 ) are up +0.37%. U.S. stock index futures this morning are moderately higher. Carry-over support from a rally in Asian markets today is underpinning stock futures after the BOJ...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Cantor Fitzgerald Lowers Price Target On Curaleaf Stock Post Q3 Earnings

Curaleaf Holdings, Inc.

Benzinga

What's In The Cards For These Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season

Several cannabis multistate operators, or MSOs, are poised to report their third-quarter financials in November. Cantor Fitzgerald's analyst Pablo Zuanic weighed in with his expectations on the upcoming earnings season and took a closer look at TerrAscend Corp. (CSE: TER) (OTCQX:

Benzinga

Trulieve Will Have Weaker Than Expected Q3 Sales, Opines This Analyst

With yet another earnings season ahead, Cantor Fitzgerald's analyst Pablo Zuanic proffered some insight into what to expect from one of the largest cannabis MSOs in the U.S. in the upcoming third quarter.

Benzinga

Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral

On the heels of President Biden’s historic announcement that he was pardoning all federal marijuana possession convictions, Cantor Fitzgerald's

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Biden's Pardon Could Help SAFE Plus, Cantor Fitzgerald Says: What Happens Now To Cannabis Stocks?

The White House confirmed Thursday that President Biden will pardon

Benzinga

Is SAFE Banking Act For Cannabis Moving Closer To Passing? This Analyst Says Yes

Cantor Fitzgerald’s analyst Pablo Zuanic, who recently met with lawmakers in the nation's capital said congressional leaders are poised to pass banking legislation for the cannabis industry in

Benzinga

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga

'Worsening Trends' In Cannabis Retail Are Here: Can The Downtrend Reverse?

Publicly traded cannabis companies have seen their stock prices plunge over the past year, with investor sentiment mainly dependent on news around federal cannabis legalization, Cantor Fitzgerald analyst Pablo Zuanic said in his recent note.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022

Benzinga

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?

On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

Benzinga

Why Should Cannabis Investors Pay Attention To Germany? These Stocks Will Benefit From Imminent Legalization

With US federal legalization stalled and its near-term outcome uncertain, cannabis stocks are taking a hit. Cantor Fitzgerald's analyst Pablo Zuanic advised investors to turn their interest to Germany, or at least for now.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

'One Of Best-In-Class' Cannabis MSOs Has 'Optionality' When States Go Recreational, Bullish Analyst Says After Results

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove

Benzinga

Where Is The Cheapest Weed In America? A Close Look At Cannabis Pricing In PA And FL

Pablo Zuanic from Cantor Fitzgerald offered an industry update, covering cannabis pricing in Pennsylvania and Florida based on retailers’ menus. “Think of this report as 'food for thought' - we are not adjusting estimates or our investment views,” Zuanic said.

The Hindu

Deutsche Bank's former India-born co-CEO Anshu Jain dies after battle with cancer

Jaipur-born Anshu Jain was diagnosed with duodenal cancer in 2017

Tribune News Service

Anshu Jain, Deutsche Bank chief in a pivotal era, dies at 59

Anshu Jain, Cantor Fitzgerald’s president who was known for his time leading Deutsche Bank traders into the lender’s investment banking heights, died five years after being diagnosed with duodenal cancer. He was 59.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Former Deutsche Bank Co-CEO Anshu Jain dies

Anshu Jain, a fomer co-CEO of Deutsche Bank, has died, according to a statement by his family on Saturday

Benzinga

Trulieve Cannabis: A Top Pick Operator In A Small Pond? Analyst Offers Model Update Post 2Q22

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a rating of Overweight for the stocks of Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and lowered its price target to $54 from $57, on “slightly reduced estimates.”

Benzinga

Cantor Analayst Pablo Zuanic Believes SAFE Banking Now "The Worst Case Scenario" in 2022

In perhaps a sign that incremental progress on federal cannabis reform is afoot, some Wall Street analysts are increasingly coming around on the idea that reform can happen this year. Cantor Fitzgerald analyst Pablo Zuanic, a noted skeptic on SAFE Banking, now believes the legislation has a real chance of…

Benzinga

Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst

Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR)

Benzinga

Cannabis In New Jersey: How Did The Market Change Since Recreational Weed Was Legalized?

On Thursday, Cantor Fitzgerald analyst Pablo Zuanic offered an update on New Jersey’s recreational cannabis market. Zuanic analyzed the competitive landscape and the changes in the recreational cannabis market in The Garden State. Although the report is not a second-quarter preview, the analyst offered an estimation of the evolution of…

Benzinga

Cantor Fitzgerald Downgrades Ratings On 2 Canadian Cannabis Stocks To Neutral, Here's Why

Cantor Fitzgerald analyst Pablo Zuanic downgraded his rating on two Canadian cannabis stocks, Auxly Cannabis Group Inc.

Benzinga

This Analyst Is Bullish For Cannabis Stocks: Can Schumer's Bill Get 60 Votes In 'Holy Grail' Scenario?

Cantor Fitzgerald analyst Pablo Zuanic doubts that the Cannabis Administration And Opportunity Act (CAOA) will get the 60 votes it needs in the Senate in order to pass due to Republican opposition.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.